Clinical Trial Update: Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating the safety and potential efficacy of stem cell-derived small extracellular vesicles in patients with retinitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Stem Cell Small Extracellular Vesicles (stem cell-derived small extracellular vesicles)

Snippet

Sponsor: Mahidol University | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: RECRUITING